- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 42.09M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $864.83M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $864.28M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $431.01M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $505.88M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $704.77M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $899.65M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.69B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.89B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.07B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.27B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.52B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.7B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 45.96M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $3.92M |
| Capex | Q1 2025 · Mar 31, 2024 | $28.13M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $75.56M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.9B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.89B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.23 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.23 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $49.51M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $17.77M |
| Net Income | Q1 2025 · Mar 31, 2024 | $10.63M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $35.86M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $45.89M |
| Revenue | Q1 2025 · Mar 31, 2024 | $314.49M |